VHB-937, a TREM2-binding MAb with efficacy in a broad range of neurodegenerative disease models
March 11, 2024
It has been previously demonstrated that TREM2 is extensively shed during chronic neuroinflammation, which hiders its function, while TREM2 activation enhances effector functions of microglia.